Skip to main content
. 2020 Oct 8;11:580380. doi: 10.3389/fendo.2020.580380

Table 5.

Association of maternal TSH with adverse pregnancy outcomes.

Outcomes Normal TSH group Mildly elevated TSH group Significantly elevated TSH group P-value
(n = 971) (n = 433) (n = 152)
PIH, n (%) 15 (1.5%) 12 (2.8%) 10 (6.6%)
 Unadjusted OR (95% CI) 1 (ref) 1.82 (0.84–3.91) 4.49 (1.98–10.18)*+ 0.002
 Adjusted OR (95% CI) 1 (ref) 2.99 (1.24–7.23) 8.18 (3.23–20.73)*+ <0.001
Preeclampsia, n (%) 5 (0.5%) 4 (0.9%) 8 (5.3%)
 Unadjusted OR (95% CI) 1 (ref) 1.80 (0.48–6.74) 10.73 (3.46–33.26)*+ <0.001
 Adjusted OR (95% CI) 1 (ref) 3.37 (0.76–15.04) 18.56 (4.77–72.21)*+ <0.001
GDM, n (%) 194 (20%) 83 (19.2%) 33 (21.7%)
 Unadjusted OR (95% CI) 1 (ref) 0.95 (0.71–1.27) 1.11 (0.73–1.68) 0.794
 Adjusted OR (95% CI) 1 (ref) 1.02 (0.75–1.38) 1.22 (0.79–1.89) 0.668
CS, n (%) 353 (36.4%) 152 (35.1%) 64 (42.1%)
 Unadjusted OR (95% CI) 1 (ref) 0.95 (0.75–1.20) 1.27 (0.90–1.80) 0.298
 Adjusted OR (95% CI) 1 (ref) 1.11 (0.85–1.44) 1.74 (1.19–2.54)*+ 0.017
Preterm delivery, n (%) 468 (48.2%) 195 (45%) 82 (53.9%)
 Unadjusted OR (95% CI) 1 (ref) 0.88 (0.70–1.11) 1.26 (0.89–1.77) 0.159
 Adjusted OR (95% CI) 1 (ref) 1.01 (0.79–1.30) 1.66 (1.15–2.40)*+ 0.023
Postpartum hemorrhage, n (%) 12 (1.2%) 10 (2.3%) 3 (2.0%)
 Unadjusted OR (95% CI) 1 (ref) 1.89 (0.81–4.41) 1.61 (0.45–5.77) 0.323
 Adjusted OR (95% CI) 1 (ref) 1.66 (0.69–4.00) 1.25 (0.34–4.62) 0.530
Placenta previa, n (%) 13 (1.3%) 6 (1.4%) 5 (3.3%)
 Unadjusted OR (95% CI) 1 (ref) 1.04 (0.39–2.74) 2.51 (0.88–7.13) 0.205
 Adjusted OR (95% CI) 1 (ref) 1.64 (0.55–4.33) 4.79 (1.53–14.93)+ 0.026
Placenta abruption, n (%) 1 (0.1%) 1 (0.2%) 0 (0%)
 Unadjusted OR (95% CI) 1 (ref) 2.25 (0.14–35.98) 0.849
 Adjusted OR (95% CI) 1 (ref) 2.64 (0.12–57.86) 0.827
Dystocia, n (%) 14 (1.4%) 5 (1.2%) 3 (2.0%)
 Unadjusted OR (95% CI) 1 (ref) 0.80 (0.29–2.23) 1.38 (0.39–4.85) 0.760
 Adjusted OR (95% CI) 1 (ref) 0.78 (0.27–2.24) 1.34 (0.37–4.90) 0.762
Low birth weight, n (%) 26 (2.7%) 16 (3.7%) 9 (5.9%)
 Unadjusted OR (95% CI) 1 (ref) 1.40 (0.74–2.63) 2.29 (1.05–4.98)+ 0.105
 Adjusted OR (95% CI) 1 (ref) 1.65 (0.81–3.36) 2.64 (1.14–6.14)+ 0.065
Preterm birth, n (%) 468 (48.2%) 195 (45%) 82 (53.9%)
 Unadjusted OR (95% CI) 1 (ref) 0.88 (0.70–1.11) 1.26 (0.89–1.77) 0.159
 Adjusted OR (95% CI) 1 (ref) 1.01 (0.79–1.30) 1.66 (1.15–2.40)*+ 0.023
Macrosomia, n (%) 47 (4.8%) 21 (4.8%) 6 (3.9%)
 Unadjusted OR (95% CI) 1 (ref) 1.00 (0.59–1.70) 0.81 (0.34–1.92) 0.886
 Adjusted OR (95% CI) 1 (ref) 1.22 (0.49–3.00) 1.19 (0.46–3.06) 0.912
Fetal distress, n (%) 17 (1.8%) 9 (2.1%) 6 (3.9%)
 Unadjusted OR (95% CI) 1 (ref) 1.19 (0.53–2.69) 2.30 (0.89–5.94) 0.224
 Adjusted OR (95% CI) 1 (ref) 1.40 (0.58–3.35) 2.58 (0.95–7.03) 0.178
Fetal asphyxia, n (%) 3 (0.3%) 2 (0.5%) 0 (0%)
 Unadjusted OR (95% CI) 1 (ref) 1.50 (0.25–8.99) 0.907
 Adjusted OR (95% CI) 1 (ref) 1.16 (0.11–12.40) 0.993
Fetal deformities, n (%) 12 (1.2%) 2 (0.5%) 0 (0%)
 Unadjusted OR (95% CI) 1 (ref) 0.37 (0.08–1.66) 0.432
 Adjusted OR (95% CI) 1 (ref) 0.82 (0.11–6.40) 0.982
Stillbirth, n (%) 9 (0.9%) 1 (0.2%) 2 (1.3%)
 Unadjusted OR (95% CI) 1 (ref) 0.25 (0.03–1.96) 1.43 (0.31–6.66) 0.341
 Adjusted OR (95% CI) 1 (ref) 0.31 (0.03–3.05) 1.37 (0.15–12.60) 0.548
Total adverse maternal outcomes, n (%) 481 (49.5%) 205 (47.3%) 85 (55.9%)
 Unadjusted OR (95% CI) 1 (ref) 0.92 (0.73–1.15) 1.29 (0.92–1.82) 0.192
 Adjusted OR (95% CI) 1 (ref) 1.04 (0.81–1.33) 1.63 (1.13–2.36)*+ 0.032
Total adverse neonatal outcomes, n (%) 617 (63.5%) 260 (60%) 105 (69.1%)
 Unadjusted OR (95% CI) 1 (ref) 0.84 (0.67–1.06) 1.26 (0.89–1.78) 0.083
 Adjusted OR (95% CI) 1 (ref) 1.03 (0.80–1.33) 1.72 (1.19–2.50)*+ 0.014

Adjusted OR: adjusted for maternal age, pregestational BMI, number of pregnancies, number of previous births, primiparity, gestational age, and gestational weight gain.

*

P < 0.05 (2.5 ≤ TSH <4.0 mIU/L vs. 4 ≤ TSH <10 mIU/L).

+

P < 0.05 (0.29 ≤ TSH <2.5 mIU/L vs. 4 ≤ TSH <10 mIU/L).